Filtrer efter Last updated date SelectEfterFørFrom - To Dato Slutdato Denne uge Denne måned Seneste uge Seneste måned Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Efterlad dette felt tomt Filter Resultater (3800) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Efterlad dette felt tomt European Medicines Agency announces next steps for the maintenance of information on medicines in accordance with mandatory Article 57(2) requirements 4 juli 2012NewsCorporateData on medicinesMedicines European Medicines Agency releases new additional guidance for development of antibacterials for public consultation 4 juli 2012NewsHumanMedicines Janssen-Cilag International NV withdraws its application for an extension of the indication for Velcade (bortezomib) 3 juli 2012Press release European Medicines Agency finalises update to guideline on renewals 2 juli 2012NewsHumanRegulatory and procedural guidanceMedicines New pharmacovigilance legislation comes into operation 2 juli 2012Press releaseCorporate European Medicines Agency welcomes new Head of Safety and Efficacy of Medicines 2 juli 2012NewsCorporateMedicines European Medicines Agency reminds companies about arrangements before and during Olympic Games 29 juni 2012NewsCorporateMedicines European Medicines Agency finalises update to diabetes guideline 29 juni 2012NewsHumanRegulatory and procedural guidanceMedicines Two modules of guideline on good pharmacovigilance practices released for public consultation 27 juni 2012NewsCorporateRegulatory and procedural guidance Ferrer Internacional, S.A. withdraws its marketing authorisation application for Egrifta (tesamorelin) 26 juni 2012Press releaseCorporate 1 … 245 246 247 248 249 Page 249 of 380 250 251 252 253 … 380
European Medicines Agency announces next steps for the maintenance of information on medicines in accordance with mandatory Article 57(2) requirements 4 juli 2012NewsCorporateData on medicinesMedicines
European Medicines Agency releases new additional guidance for development of antibacterials for public consultation 4 juli 2012NewsHumanMedicines
Janssen-Cilag International NV withdraws its application for an extension of the indication for Velcade (bortezomib) 3 juli 2012Press release
European Medicines Agency finalises update to guideline on renewals 2 juli 2012NewsHumanRegulatory and procedural guidanceMedicines
European Medicines Agency welcomes new Head of Safety and Efficacy of Medicines 2 juli 2012NewsCorporateMedicines
European Medicines Agency reminds companies about arrangements before and during Olympic Games 29 juni 2012NewsCorporateMedicines
European Medicines Agency finalises update to diabetes guideline 29 juni 2012NewsHumanRegulatory and procedural guidanceMedicines
Two modules of guideline on good pharmacovigilance practices released for public consultation 27 juni 2012NewsCorporateRegulatory and procedural guidance
Ferrer Internacional, S.A. withdraws its marketing authorisation application for Egrifta (tesamorelin) 26 juni 2012Press releaseCorporate